0.012501
0.000000
0.000000
0.000000
0.012501
0.000000
0.000000
0.000000
0.012501
0.00000
0.00000
0.00000
Yadav, M.K.
Leman, L.J.
Price, D.J.
Brooks 3rd, C.L.
Stout, C.D.
Ghadiri, M.R.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
48
90.00
90.00
90.00
79.992
79.992
79.992
C2 H4 O
44.053
ACETYL GROUP
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
H2 O
18.015
WATER
non-polymer
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
Biochemistry
BICHAW
0033
0006-2960
45
4463
4473
10.1021/bi060092q
16584182
Coiled coils at the edge of configurational heterogeneity. Structural analyses of parallel and antiparallel homotetrameric coiled coils reveal configurational sensitivity to a single solvent-exposed amino acid substitution.
2006
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
180.0
1
CCD
2005-07-12
ADSC CCD
SINGLE WAVELENGTH
M
x-ray
1
0.979
1.0
BL11-1
SSRL
0.979
SYNCHROTRON
SSRL BEAMLINE BL11-1
4030.802
General control protein GCN4
RESIDUES 249-281
YES
2
syn
polymer
18.015
water
18
nat
water
Amino acid biosynthesis regulatory protein
no
yes
(ACE)RMKQIEDKLEEILSKLYHISNELARIKKLLGER
XRMKQIEDKLEEILSKLYHISNELARIKKLLGER
A,B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
1
2.7
54
0.00
2M NACL, 10% PEG 6K, pH 0.00
audit_author
citation
citation_author
entity
entity_name_com
entity_src_nat
pdbx_entity_src_syn
struct_ref
struct_ref_seq
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Source and taxonomy
Structure summary
1
0
2006-04-06
1
1
2011-05-08
1
2
2011-07-13
1
3
2018-11-07
_audit_author.name
_citation.page_last
_citation.pdbx_database_id_DOI
_citation.title
_citation_author.name
_entity.pdbx_description
_entity.src_method
_entity_name_com.name
HELIX CAPPING IN THE GCN4 LEUCINE ZIPPER
GCN4 LEUCINE ZIPPER COMPLEXED WITH SPECIFIC ATF/CREB SITE DEOXYRIBONUCLEIC ACID
ATOMIC STRUCTURE OF THE ECTODOMAIN FROM HIV -1 GP41
THE STRUCTURE OF AN HIV-1 SPECIFIC CELL ENTRY INHIBITOR INCOMPLEX WITH THE HIV-1 GP41 TRIMERIC CORE
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
GCN4 LEUCINE ZIPPER CORE MUTANT P-LI
HUMAN VIMENTIN COIL 2B FRAGMENT LINKED TO GCN4 LEUCINE ZIPPER (Z2B)
CRYSTAL STRUCTURE OF C14LINKMID/IQN17: A CROSS-LINKED INHIBITOR OF HIV-1 ENTRY BOUND TO THE GP41 HYDROPHOBIC POCKET
GLYTM1BZIP: A CHIMERIC PEPTIDE MODEL OF THE N-TERMINUS OF ARAT SHORT ALPHA TROPOMYOSIN WITH THE N-TERMINUS ENCODED BYEXON 1B
COILED COIL TRIMER GCN4-PVLS SER AT BURIED D POSITION
GCN4-PVLT COILED-COIL TRIMER WITH THREONINE AT THE D(12)POSITION
GCN4-PVTL COILED-COIL TRIMER WITH THREONINE AT THE A(16)POSITION
GCN4-PVSL COILED-COIL TRIMER WITH SERINE AT THE A(16)POSITION
CRYSTAL STRUCTURE OF THE C-TERMINAL REGION OF STRIATEDMUSCLE ALPHA-TROPOMYOSIN AT 2.7 ANGSTROM RESOLUTION
PLACEMENT OF THE STRUCTURAL PROTEINS IN SINDBIS VIRUS
CRYSTAL STRUCTURE OF A ZIF23-GCN4 CHIMERA BOUND TO DNA
VISUALIZING AN UNSTABLE COILED COIL: THE CRYSTAL STRUCTUREOF AN N-TERMINAL SEGMENT OF THE SCALLOP MYOSIN ROD
CRYSTAL STRUCTURE OF GCN4-PIQ, A TRIMERIC COILED COIL WITH BURIED POLAR RESIDUES
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A TRIGONAL AUTOMATICSOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL AUTOMATIC SOLUTION
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TRIGONAL FORM
ANTIPARALLEL TRIMER OF GCN4-LEUCINE ZIPPER CORE MUTANT ASN16A TETRAGONAL FORM
GCN4-LEUCINE ZIPPER CORE MUTANT AS N16A COMPLEXED WITH BENZENE
TMZIP: A CHIMERIC PEPTIDE MODEL OF THE N- TERMINUS OF ALPHA TROPOMYOSIN, NMR, 15 STRUCTURES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
STRUCTURE BASED ENGINEERING OF INTERNAL MOLECULAR SURFACES OF FOUR HELIX BUNDLES
AN ANTI-PARALLEL FOUR HELIX BUNDLE MUTANT PLI-E20C
AN ANTI-PARALLEL FOUR HELIX BUNDLE ( ACETIMIDE MODIFICATION).
AN ANTI-PARALLEL FOUR HELIX BUNDLE.
ABA DOES NOT AFFECT TOPOLOGY OF PLI.
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL FOUR HELIX BUNDLE
AN ANTI-PARALLEL TO PARALLEL SWITCH.
GCN4 (BASIC REGION, LEUCINE ZIPPER) COMPLEX WITH AP-1 DEOXYRIBONUCLEIC ACID
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16ABA IN THE TRIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16LYS IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE DIMERIC STATE
GCN4-LEUCINE ZIPPER CORE MUTANT ASN16GLN IN THE TRIMERIC STATE
LEUCINE ZIPPER MONOMER (NMR, 20 STRUCTURES)
ANTIPARALLEL FOUR-STRANDED COILED COIL SPECIFIED BY A 3-3-1HYDROPHOBIC HEPTAD REPEAT
ANTIPARALLEL FOUR-STRANDED COILED COIL SPECIFIED BY A 3-3-1HYDROPHOBIC HEPTAD REPEAT
PLI MUTANT E20C L16G Y17H, ANTIPARALLEL
ANTIPARALLEL CONFIGURATION OF PLI E20S
PLI E20C IS ANTIPARALLEL
GCN4 BASIC DOMAIN, LEUCINE ZIPPER COMPLEXED WITH ATF/CREB SITE DEOXYRIBONUCLEIC ACID
GCN4 LEUCINE ZIPPER
PDBE
Y
PDBE
2006-01-16
REL
HOH
water
4932
Baker's yeast
Saccharomyces cerevisiae
sample
1
34
ENGINEERED RESIDUE IN CHAIN A, GLU 268 TO SER
ENGINEERED RESIDUE IN CHAIN B, GLU 268 TO SER
HOH
2001
2
HOH
HOH
2001
A
HOH
2002
2
HOH
HOH
2002
A
HOH
2003
2
HOH
HOH
2003
A
HOH
2004
2
HOH
HOH
2004
A
HOH
2005
2
HOH
HOH
2005
A
HOH
2006
2
HOH
HOH
2006
A
HOH
2007
2
HOH
HOH
2007
A
HOH
2008
2
HOH
HOH
2008
A
HOH
2009
2
HOH
HOH
2009
A
HOH
2010
2
HOH
HOH
2010
A
HOH
2011
2
HOH
HOH
2011
A
HOH
2012
2
HOH
HOH
2012
A
HOH
2001
2
HOH
HOH
2001
B
HOH
2002
2
HOH
HOH
2002
B
HOH
2003
2
HOH
HOH
2003
B
HOH
2004
2
HOH
HOH
2004
B
HOH
2005
2
HOH
HOH
2005
B
HOH
2006
2
HOH
HOH
2006
B
n
1
0
A
n
2
1
A
MET
2
n
3
MET
2
A
LYS
3
n
4
LYS
3
A
GLN
4
n
5
GLN
4
A
ILE
5
n
6
ILE
5
A
GLU
6
n
7
GLU
6
A
ASP
7
n
8
ASP
7
A
LYS
8
n
9
LYS
8
A
LEU
9
n
10
LEU
9
A
GLU
10
n
11
GLU
10
A
GLU
11
n
12
GLU
11
A
ILE
12
n
13
ILE
12
A
LEU
13
n
14
LEU
13
A
SER
14
n
15
SER
14
A
LYS
15
n
16
LYS
15
A
LEU
16
n
17
LEU
16
A
TYR
17
n
18
TYR
17
A
HIS
18
n
19
HIS
18
A
ILE
19
n
20
ILE
19
A
SER
20
n
21
SER
20
A
ASN
21
n
22
ASN
21
A
GLU
22
n
23
GLU
22
A
LEU
23
n
24
LEU
23
A
ALA
24
n
25
ALA
24
A
ARG
25
n
26
ARG
25
A
ILE
26
n
27
ILE
26
A
LYS
27
n
28
LYS
27
A
LYS
28
n
29
LYS
28
A
LEU
29
n
30
LEU
29
A
LEU
30
n
31
LEU
30
A
GLY
31
n
32
GLY
31
A
GLU
32
n
33
GLU
32
A
n
34
33
A
n
1
0
B
n
2
1
B
MET
2
n
3
MET
2
B
LYS
3
n
4
LYS
3
B
GLN
4
n
5
GLN
4
B
ILE
5
n
6
ILE
5
B
GLU
6
n
7
GLU
6
B
ASP
7
n
8
ASP
7
B
LYS
8
n
9
LYS
8
B
LEU
9
n
10
LEU
9
B
GLU
10
n
11
GLU
10
B
GLU
11
n
12
GLU
11
B
ILE
12
n
13
ILE
12
B
LEU
13
n
14
LEU
13
B
SER
14
n
15
SER
14
B
LYS
15
n
16
LYS
15
B
LEU
16
n
17
LEU
16
B
TYR
17
n
18
TYR
17
B
HIS
18
n
19
HIS
18
B
ILE
19
n
20
ILE
19
B
SER
20
n
21
SER
20
B
ASN
21
n
22
ASN
21
B
GLU
22
n
23
GLU
22
B
LEU
23
n
24
LEU
23
B
ALA
24
n
25
ALA
24
B
ARG
25
n
26
ARG
25
B
ILE
26
n
27
ILE
26
B
LYS
27
n
28
LYS
27
B
LYS
28
n
29
LYS
28
B
LEU
29
n
30
LEU
29
B
LEU
30
n
31
LEU
30
B
GLY
31
n
32
GLY
31
B
GLU
32
n
33
GLU
32
B
n
34
33
B
author_and_software_defined_assembly
PQS
4
tetrameric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
0.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
1.0000000000
0.0000000000
18_545
-x+1/4,z-1/4,y+1/4
crystal symmetry operation
19.9980000000
-19.9980000000
19.9980000000
1
A
HOH
2011
C
HOH
1
A
N
MET
2
A
N
MET
3
1
Y
1
A
CG
MET
2
A
CG
MET
3
1
Y
1
A
SD
MET
2
A
SD
MET
3
1
Y
1
A
CE
MET
2
A
CE
MET
3
1
Y
1
A
CB
LYS
3
A
CB
LYS
4
1
Y
1
A
CG
LYS
3
A
CG
LYS
4
1
Y
1
A
CD
LYS
3
A
CD
LYS
4
1
Y
1
A
CE
LYS
3
A
CE
LYS
4
1
Y
1
A
NZ
LYS
3
A
NZ
LYS
4
1
Y
1
A
CG
GLN
4
A
CG
GLN
5
1
Y
1
A
CD
GLN
4
A
CD
GLN
5
1
Y
1
A
OE1
GLN
4
A
OE1
GLN
5
1
Y
1
A
NE2
GLN
4
A
NE2
GLN
5
1
Y
1
A
CG1
ILE
5
A
CG1
ILE
6
1
Y
1
A
CD1
ILE
5
A
CD1
ILE
6
1
Y
1
A
CG
LYS
8
A
CG
LYS
9
1
Y
1
A
CD
LYS
8
A
CD
LYS
9
1
Y
1
A
CE
LYS
8
A
CE
LYS
9
1
Y
1
A
NZ
LYS
8
A
NZ
LYS
9
1
Y
1
A
CD
LYS
15
A
CD
LYS
16
1
Y
1
A
CE
LYS
15
A
CE
LYS
16
1
Y
1
A
NZ
LYS
15
A
NZ
LYS
16
1
Y
1
A
CG
LYS
28
A
CG
LYS
29
1
Y
1
A
CD
LYS
28
A
CD
LYS
29
1
Y
1
A
CE
LYS
28
A
CE
LYS
29
1
Y
1
A
NZ
LYS
28
A
NZ
LYS
29
1
Y
1
B
N
MET
2
B
N
MET
3
1
Y
1
B
CB
MET
2
B
CB
MET
3
1
Y
1
B
CG
MET
2
B
CG
MET
3
1
Y
1
B
SD
MET
2
B
SD
MET
3
1
Y
1
B
CE
MET
2
B
CE
MET
3
1
Y
1
B
CG
LYS
3
B
CG
LYS
4
1
Y
1
B
CD
LYS
3
B
CD
LYS
4
1
Y
1
B
CE
LYS
3
B
CE
LYS
4
1
Y
1
B
NZ
LYS
3
B
NZ
LYS
4
1
Y
1
B
CD1
ILE
5
B
CD1
ILE
6
1
Y
1
B
CB
GLU
6
B
CB
GLU
7
1
Y
1
B
CG
GLU
6
B
CG
GLU
7
1
Y
1
B
CD
GLU
6
B
CD
GLU
7
1
Y
1
B
OE1
GLU
6
B
OE1
GLU
7
1
Y
1
B
OE2
GLU
6
B
OE2
GLU
7
1
Y
1
B
CG
LYS
8
B
CG
LYS
9
1
Y
1
B
CD
LYS
8
B
CD
LYS
9
1
Y
1
B
CE
LYS
8
B
CE
LYS
9
1
Y
1
B
NZ
LYS
8
B
NZ
LYS
9
1
Y
1
B
CD
GLU
10
B
CD
GLU
11
1
Y
1
B
OE1
GLU
10
B
OE1
GLU
11
1
Y
1
B
OE2
GLU
10
B
OE2
GLU
11
1
Y
1
B
CD2
LEU
29
B
CD2
LEU
30
1
Y
1
A
ACE
0
A
ACE
1
1
Y
1
A
ARG
1
A
ARG
2
1
Y
1
A
ARG
33
A
ARG
34
1
Y
1
B
ACE
0
B
ACE
1
1
Y
1
B
ARG
1
B
ARG
2
1
Y
1
B
ARG
33
B
ARG
34
1
Y
44.90
0.904
0.884
HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. HIGH R-FREE BUT CONSISTENT WITH RELATED SEQUENCES IN SAME LATTICE. ELECTRON DENSITY MAPS ARE EXCELLENT.
0.319
0.282
0.284
1.90
56.52
326
6759
4.600
96.4
3.802
0.113
RANDOM
1
THROUGHOUT
MOLECULAR REPLACEMENT
0.174
0.166
0.80
0.80
1.20
MAXIMUM LIKELIHOOD
MASK
1.90
56.52
18
483
0
0
465
0.021
0.021
467
1.546
2.014
624
4.538
5.000
60
30.820
25.789
19
17.585
15.000
91
20.425
15.000
2
0.100
0.200
74
0.007
0.020
330
0.206
0.200
201
0.294
0.200
322
0.155
0.200
13
0.187
0.200
27
0.074
0.200
1
1.392
1.500
321
2.247
2.000
471
3.395
3.000
174
5.028
4.500
153
0.5420
0.4600
1.95
28
506
20
1.900
50.000
2CCE
7118
2.000
0.06000
1
20.6000
10.900
100.0
refinement
REFMAC
5.2.0005
data reduction
HKL-2000
data scaling
HKL-2000
phasing
PHASER
GENERAL CONTROL PROTEIN GCN4
Parallel Configuration of pLI E20S
1
N
N
1
N
N
2
N
N
2
N
N
A
LYS
3
A
LYS
4
HELX_P
A
LEU
30
A
LEU
31
1
1
28
B
LYS
3
B
LYS
4
HELX_P
B
GLU
32
B
GLU
33
1
2
30
FOUR HELIX BUNDLE
FOUR HELIX BUNDLE, ANTIPARALLEL, PARALLEL, PLI, DNA-BINDING, NUCLEAR PROTEIN, TRANSCRIPTION, TRANSCRIPTION REGULATION, ACTIVATOR, AMINO-ACID BIOSYNTHESIS
GCN4_YEAST
UNP
1
249
P03069
RMKQLEDKVEELLSKNYHLENEVARLKKLVGER
249
281
2CCE
1
33
P03069
A
1
2
34
249
281
2CCE
1
33
P03069
B
1
2
34
1
acetylation
ACE
0
2CCE
A
P03069
UNP
1
1
LEU
engineered mutation
ILE
5
2CCE
A
P03069
UNP
253
6
1
VAL
engineered mutation
LEU
9
2CCE
A
P03069
UNP
257
10
1
LEU
engineered mutation
ILE
12
2CCE
A
P03069
UNP
260
13
1
ASN
engineered mutation
LEU
16
2CCE
A
P03069
UNP
264
17
1
LEU
engineered mutation
ILE
19
2CCE
A
P03069
UNP
267
20
1
GLU
engineered mutation
SER
20
2CCE
A
P03069
UNP
268
21
1
VAL
engineered mutation
LEU
23
2CCE
A
P03069
UNP
271
24
1
LEU
engineered mutation
ILE
26
2CCE
A
P03069
UNP
274
27
1
VAL
engineered mutation
LEU
30
2CCE
A
P03069
UNP
278
31
2
acetylation
ACE
0
2CCE
B
P03069
UNP
1
2
LEU
engineered mutation
ILE
5
2CCE
B
P03069
UNP
253
6
2
VAL
engineered mutation
LEU
9
2CCE
B
P03069
UNP
257
10
2
LEU
engineered mutation
ILE
12
2CCE
B
P03069
UNP
260
13
2
ASN
engineered mutation
LEU
16
2CCE
B
P03069
UNP
264
17
2
LEU
engineered mutation
ILE
19
2CCE
B
P03069
UNP
267
20
2
GLU
engineered mutation
SER
20
2CCE
B
P03069
UNP
268
21
2
VAL
engineered mutation
LEU
23
2CCE
B
P03069
UNP
271
24
2
LEU
engineered mutation
ILE
26
2CCE
B
P03069
UNP
274
27
2
VAL
engineered mutation
LEU
30
2CCE
B
P03069
UNP
278
31
213
P 41 3 2